17th June 2024
Category: Press Releases
14th November 2023
Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
24th October 2023
Day Zero Diagnostics Names Jeff Mirviss Chair of Board of Directors
10th October 2023
Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at IDWeek
4th October 2023
Day Zero Diagnostics Welcomes Microbiology and Genomic Researcher Dr. Patricia Simner to Advisory Board
20th September 2023
Day Zero Diagnostics Announces Completion of $16M Financing Round
29th August 2023
DZD Awarded $300K SBIR Grant for Development of Microbiome Diagnostics
9th November 2022
Day Zero Diagnostics Welcomes Healthcare Business Leader Gail Marcus to its Board
20th October 2022
Day Zero Diagnostics Awarded $8.2 Million in Additional CARB-X Funding To Support Ongoing Development of its Infectious Disease Rapid Diagnostic
25th August 2022
Day Zero Diagnostics Welcomes Molecular Diagnostics Experts to its Advisory Board
8th April 2022
Day Zero Diagnostics Announces the Launch of Day Zero Lab Services
8th February 2022
Day Zero Diagnostics Announces Completion of $21M Financing
11th October 2021
Day Zero Diagnostics Wins the New Life Sciences Diagnostic Category at the Annual UCSF Health Awards
30th September 2021
DZD Wins Disruptive Technology Award at the 2021 AACC Annual Scientific Meeting
9th December 2020
Day Zero Diagnostics Doubles Down on epiXact® Service for Investigating Healthcare-Associated Infection Outbreaks Supported by New NIH Funding Award
17th November 2020
DZD Announces High-Caliber Additions to Leadership Team and Advisory Board
3rd August 2020
Day Zero Diagnostics Moves Headquarters to SmartLabs at Boston Landing
21st October 2020
DZD Announces Positive Data from Multiple Studies Demonstrating Promise of New Technology
2nd June 2020
DZD Research Highlighted in Two Publications on Plasmid-Mediated Antibiotic Resistance
11th May 2020